Healthcare -
Biotechnology - NASDAQ - US
$ 46.52
-0.853 %
$ 1.78 B
Market Cap
-12.41
P/E
TARS - COST OF REVENUE
Cost of Revenue TARS - Tarsus Pharmaceuticals, Inc.
1.59 M
LAST VALUE
-12.38%
2 YEAR CAGR
336.96%
5 YEAR CAGR
0.00%
10 YEAR CAGR